Drug Shortage Report for MERREM
| Report ID | 20374 |
| Drug Identification Number | 02218496 |
| Brand name | MERREM |
| Common or Proper name | Meropenem |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MEROPENEM |
| Strength(s) | 1G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 30 mL vial |
| ATC code | J01DH |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2017-08-29 |
| Estimated end date | |
| Actual end date | 2018-08-28 |
| Shortage status | Resolved |
| Updated date | 2018-08-29 |
| Company comments | The product has been discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-08-25 | French | Compare |
| v1 | 2017-08-25 | English | Compare |